Analgesia in Laparoscopic Cholecystectomy

• Status: Completed
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators hypothesis is that perioperative infusion of 0.75 ropivacaine in patients undergoing laparoscopic cholecystectomy may modify the intensity of postoperative pain or the analgesic consumption during the first 24 hours.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Athens
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Patients aged 30-70 years American Society of Anesthesiology (ASA) physical status I-III

• Scheduled for laparoscopic cholecystectomy

Exclusion Criteria:

• Patients with chronic pain and/or on analgesics for the last month,

• Patients with central nervous, kidney and liver disease, or allergy to local anesthetics